High-dose steroid therapy for CNS inflammatory diseases increases INR in patients taking oral vitamin K antagonist

J Neurol. 2019 Dec;266(12):3160-3161. doi: 10.1007/s00415-019-09515-6. Epub 2019 Aug 21.

Authors

Stefano Gelibter¹, Mario Orrico¹, Tommaso Croese¹, Luca Bosco¹, Vittorio Martinelli¹, Francesca Sangalli¹, Massimo Filippi^{2

3

4}

Affiliations

¹ Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
² Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.
³ Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.
⁴ Vita-Salute San Raffaele University, Milan, Italy. filippi.massimo@hsr.it.

PMID: 31435772
DOI: 10.1007/s00415-019-09515-6

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Anticoagulants / therapeutic use*
Demyelinating Autoimmune Diseases, CNS / drug therapy*
Female
Glucocorticoids / adverse effects*
Humans
International Normalized Ratio*
Male
Methylprednisolone / adverse effects*
Middle Aged
Vitamin K / antagonists & inhibitors
Warfarin / therapeutic use*

Substances

Anticoagulants
Glucocorticoids
Vitamin K
Warfarin
Methylprednisolone